Bangladesh approves China`s Sinopharm vaccine shot...

Dhaka, Sunday   09 May 2021

Bangladesh approves China`s Sinopharm vaccine shot

 Staff Correspondent

 Published: 05:56 PM, 28 April 2021   Updated: 07:23 PM, 28 April 2021

Bangladesh approves China`s Sinopharm vaccine shot

Bangladesh approves China`s Sinopharm vaccine shot

Bangladesh's drug regulator on Wednesday has decided to approve the Chinese Sinopharm vaccine for emergency use against COVID-19 in the country.

Earlier on Wednesday, a virtual meeting of the Cabinet Committee on Economic Affairs was held under the chairmanship of Finance Minister AHM Mustafa Kamal. At that meeting, the Cabinet Committee on Economic Affairs gave ethical approval to Russia and China for the production of coronavirus vaccine in Bangladesh.

After the meeting, the finance minister said that it has not been decided yet which company will manufacture the vaccine.

The meeting was attended by members of the committee, senior secretaries of the cabinet divisions, secretaries of the concerned ministries and senior officials. At the end of the meeting, Shahida Akhter, the Additional Secretary of the Cabinet highlighted various aspects of the approved proposals.

She said Russia's Sputnik V and China's Sinofarm vaccine had been approved for production in the country by local company.

She added that several companies in the country have the capacity to manufacture these two vaccines. However, she did not say which organizations have this capability.

Earlier, on Tuesday the drug regulator approved the Russian Sputnik V vaccine for emergency use against COVID-19. The approval was given by the Committee on Emergency Public Health Medicines, Experimental Medicines, Vaccines and Medical Equipment formed by the Ministry of Health.

The decision to approve the vaccine was taken at a meeting of the Department of Drug Administration. As a result, there were no legal restrictions on the import and use of the Russian Corona vaccine. If it wants to buy now, Russia will be able to vaccinate Bangladesh from next month, according to official documents.

Bangladesh, a country of 170 million has been relying on the AstraZeneca vaccine so far, and around 6 million of it citizens have been inoculated.

This week its stopped administered first doses, however, amid uncertainty over when shipments from India would resume.

Bangladesh has an agreement with the Serum Institute of India, the world’s biggest vaccine maker, for 30 million doses of AstraZeneca vaccine but has received only 7 million so far.